---
title: "{{ replace .File.ContentBaseName "-" " " | title }}"
date: {{ .Date }}
showToc: true
summary: ""
tags: ["case-control-study", "observational-study", "strobe"]
draft: true
---

**Study Design:** Case-Control Study

## Title and Abstract

**Study Design Term:** Case-Control Study

**Abstract Summary:** [Provide an informative and balanced summary of what was done and what was found]

## Introduction

### Background/Rationale
[Explain the scientific background and rationale for the investigation being reported]

### Objectives
[State specific objectives, including any prespecified hypotheses]

## Methods

### Study Design
[Present key elements of study design]

### Setting
- **Locations:** [Describe settings and locations]
- **Relevant Dates:**
  - Recruitment period:
  - Data collection period:

### Participants

**Cases:**
- **Eligibility Criteria:**
  - Inclusion:
  - Exclusion:
- **Sources and Methods of Case Ascertainment:**
- **Rationale for Choice of Cases:**

**Controls:**
- **Eligibility Criteria:**
  - Inclusion:
  - Exclusion:
- **Sources and Methods of Control Selection:**
- **Rationale for Choice of Controls:**

**Matching (if applicable):**
- Matching criteria:
- Number of controls per case:

### Variables
[Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable]

**Outcomes:**
-

**Exposures:**
-

**Predictors:**
-

**Potential Confounders:**
-

**Effect Modifiers:**
-

### Data Sources/Measurement
[For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group]

### Bias
[Describe any efforts to address potential sources of bias]

### Study Size
[Explain how the study size was arrived at]

### Quantitative Variables
[Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why]

### Statistical Methods

**(a) Statistical Methods for Confounding:**
[Describe all statistical methods, including those used to control for confounding]

**(b) Subgroups and Interactions:**
[Describe any methods used to examine subgroups and interactions]

**(c) Missing Data:**
[Explain how missing data were addressed]

**(d) Matching:**
[If applicable, explain how matching of cases and controls was addressed]

**(e) Sensitivity Analyses:**
[Describe any sensitivity analyses]

## Results

### Participants

**(a) Numbers at Each Stage:**

**For Cases:**
- Potentially eligible:
- Examined for eligibility:
- Confirmed eligible:
- Included in study:
- Analysed:

**For Controls:**
- Potentially eligible:
- Examined for eligibility:
- Confirmed eligible:
- Included in study:
- Analysed:

**(b) Reasons for Non-participation:**
[Give reasons for non-participation at each stage, separately for cases and controls]

**(c) Flow Diagram:**
[Consider including a flow diagram]

### Descriptive Data

**(a) Participant Characteristics:**
[Give characteristics of study participants (demographic, clinical, social) and information on exposures and potential confounders, separately for cases and controls]

**(b) Missing Data:**
[Indicate number of participants with missing data for each variable of interest, separately for cases and controls]

### Outcome Data
[Report numbers in each exposure category, or summary measures of exposure, separately for cases and controls]

### Main Results

**(a) Estimates and Precision:**
- Unadjusted estimates:
- Confounder-adjusted estimates (95% CI):
- Confounders adjusted for and rationale:

**(b) Category Boundaries:**
[Report category boundaries when continuous variables were categorized]

**(c) Absolute Risk:**
[If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period]

### Other Analyses
[Report other analyses doneâ€”e.g., analyses of subgroups and interactions, and sensitivity analyses]

## Discussion

### Key Results
[Summarize key results with reference to study objectives]

### Limitations
[Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias]

### Interpretation
[Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence]

### Generalisability
[Discuss the generalisability (external validity) of the study results]

## Other Information

### Funding
[Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based]

## Data & Code

**Data Availability:**

**Code Repository:**

## References

1.
